Mark Ahrens-townsend
Biochemistry
Kane Biotech Inc.
Canada
Biography
Mark Ahrens-Townsend joined Kane Biotech in May 2015 as President and CEO. Mr. Ahrens-Townsend brings extensive expertise in leadership, strategic planning, and business development. He has spent 30+ years in the Technology, Engineering and Venture Capital industries. For the last 19 years Mr. Ahrens-Townsend has held senior executive roles, twice as President and CEO of two publicly traded technology companies, and has also served extensively on the boards and committees of several private and publicly held companies. Mr. Ahrens-Townsend holds B.Sc. (Engineering) and MBA (Finance) degrees from the University of Manitoba.
Research Interest
Biochemistry
